Al Azhar university
Cairo, 11825, Egypt
NCT Number: NCT05413096
The combination of diclofenac and propolis could enhance the healing of recurrent aphthous ulcers, instantly relieve symptoms, improve the quality of life, and present a de novo and cost-effective regime help in oral ulcer treatment. This study aimed to evaluate the influence of diclofenac and propolis combination as a gel in the treatment of recurrent oral ulceration
Looking for future studies?
Notify Me5 year–70 year
All sexes
Interventional
Early Phase 1
Cairo, 11825, Egypt
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be divided into two groups: the first one will be treated with a combination of diclofenac 3% (10 mg/g, 60 g, EMS) and Propolis 5% gel and the second one is placebo group. Participants will be allocated randomly. The patients will be asked to apply gel 2 times per day. The patients will be instructed, not to eat or drink for 1 h after application of the gel
placebo
Time frame: 10 days
patient response
Time frame: 10 days
size
Al-Azhar University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00230191
Digestive System Diseases, Gastroenteritis
Los Angeles, California, United States
View Trial DetailsNCT03689712
Carcinoma, Carcinoma, Squamous Cell
Gilbert, Arizona, United States
View Trial DetailsNCT02229136
Breast Diseases, Breast Neoplasms
US, Texas, United States
View Trial DetailsNCT00323518
Mouth Diseases, Oral Mucositis
Little Rock, Arkansas, United States
View Trial Details